Conference Overview

Our 2018 FOD/OAA International Metabolic Conference is for parents, family members, affected individuals, professionals and exhibitors that have an interest in Metabolic Disorders. It is only through generous donations and sponsorships that the FOD Group and OAA are able to offer such an important opportunity every two years to Families and Professionals eager to learn more about our disorders. Our premier Sponsor/Host is Mayo Medical Laboratories.

Fatty Oxidation Disorders and Organic Acidemias are a group of rare metabolic disorders whereby fatty acids and protein, respectively, cannot be broken down in the body to be used as energy, especially in times of fasting or illness, and are treated through dietary changes and medications.  When undiagnosed, severe medical complications and/or death can occur.

The importance of our Family Conference is to allow our members to meet other parents and professionals and learn more about their own or their child’s rare metabolic disorder. The focus for this conference is for Families to learn more about the medical management, nutrition and the social needs of caring for yourself or a child with a chronic disorder, specifically those with rare metabolic disorders. 

Conference Video Presentations


Keynote Speaker:

What have I been doing since 2002?  Milestones of a personal journey and memorable encounters along with metabolic path.

Piero Rinaldo, MD, PhD
T. Denny Sanford Professor of Pediatrics and Professor of Laboratory Medicine

Clinical Management of Organic Acidemias and OAA Natural History Registry

Kimberly A Chapman MD PhD
Associate Professor of Pediatrics
George Washington University
Children’s National Rare Disease Institute

Emergency Protocols and Q & A Session

D. Holmes Morton MD,
Founding Pediatrician 

Chuck Hehmeyer, Attorney Raynes Lawn Hehmeyer, Philadelphia, PA

Young Adult Panel
Novel Therapies for Organic Acidemias

Jerry Vockley, MD, PhD

University of Pittsburgh,
Cleveland Family Professor of Pediatric Research, Professor of Human Genetics, 
Children’s Hospital of Pittsburgh,
Chief of Medical Genetics, Director of the Center for Rare Disease Therapy 

Mitochondrial Dysfunction in the Organic Acidemias

Mark Korson, MD

VMP Genetics, LLC
Director of Physician Support
Director of Education 

What happens after I visit NIH for a Research Study?

Oleg Shchelochkov, M.D.
Medical Genomics and Metabolic Genetics Branch
National Human Genome Research Institute

Drug Discovery & Development How Patients & Families Can Help

John Reardon, PhD

Hemoshear Therapeutics LLC
Head of Research and Development

Day 2 - Joint Session

What are the limits of newborn screening?

Susan A. Berry, MD

Department of Pediatrics
University of Minnesota

I teach but you teach better.

Mark Korson, MD
VMP Genetics, LLC
Director of Physician Support
Director of Education 

Neuropsychology and Metabolic Conditions:  The Neurocognitive Profile of FOD/OAA and the benefits of neuropsychological assessment

Christopher Boys, PhD, LP

Pediatric Neuropsychologist
​Associate Professor of Pediatrics
University of Minnesota

OAA Conference Sponsors

Thanks for coming!
Select Language